文献速递湿疹皮炎与荨麻疹

胆汁淤积性瘙痒:新兴机制与治疗

Cholestatic pruritus: Emerging mechanisms and therapeutics.
PubMed 文献 · J Am Acad Dermatol · 2019-04-19

本文通过系统文献综述评估胆汁淤积性瘙痒的传统治疗策略、当前病理生理认识及新疗法作用。文章讨论胆汁酸、溶血磷脂酸和胆红素作为潜在瘙痒介质的发现,并指出清除或调节致痒物质的新疗法已获观察性队列研究和随机对照试验支持,但仍需进一步研究确认病理生理以开发靶向治疗。

要点

  • 胆汁淤积性瘙痒是多因素所致,较组胺驱动的荨麻疹更难治疗。
  • 胆汁酸、溶血磷脂酸和胆红素可能是胆汁淤积性瘙痒的重要介质。
  • 清除或调节致痒物质的新疗法已获观察性队列和随机对照试验支持。

核心结论

  • 胆汁淤积性瘙痒为多因素致病,现有疗法常无效且不良反应较多,新疗法显示前景但需进一步研究确认病理生理以开发靶向治疗。

研究设计与样本

  • 系统文献综述,评估胆汁淤积性瘙痒的传统治疗策略、当前病理生理认识及新疗法作用。

主要发现

  • 胆汁酸、溶血磷脂酸和胆红素被讨论为胆汁淤积性瘙痒的潜在重要介质。
  • 旨在清除或调节致痒物质的新疗法已获观察性队列研究和随机对照试验支持。

临床怎么用

  • 临床可关注清除或调节致痒物质的新疗法,但需注意现有疗法并非总是有效且不良反应较多。

局限性

  • 需进一步研究确认胆汁淤积性瘙痒的病理生理,以便开发靶向治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Patients suffering from cholestasis often report experiencing a debilitating, unrelenting itch. In contrast to conditions, such as urticaria, in which histamine primarily drives itch (pruritus), cholestatic pruritus is multifactorial and more difficult to treat. Existing therapies are not always effective and have undesirable adverse effect profiles. Here, we conducted a systematic literature review to evaluate conventional treatment strategy, current pathophysiologic understanding, and the role of new therapies in the context of cholestatic pruritus. We discuss novel findings implicating bile acids, lysophosphatidic acid, and bilirubin as potential important mediators of cholestatic itch. New therapies that aim to remove or modulate pruritogens have been supported in observational cohort studies and randomized controlled trials. Although these new therapies show promise, further research is needed to confirm the pathophysiology of cholestatic pruritus so that targeted therapy can be developed.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Patel SP, Vasavda C, Ho B, et al. Cholestatic pruritus: Emerging mechanisms and therapeutics. J Am Acad Dermatol. 2019. PMID: 31009666. doi:10.1016/j.jaad.2019.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。